Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of GPN00884 eye drops for slowing myopia progression in children
CTR20253747Phase 2Active
- Sponsor
- Grand Pharmaceutical Group
- Start
- Oct 2025
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of GPN00884 in myopia, sponsored by Grand Pharmaceutical Group. Started Oct 2025; status: active.
02
Drugs
GPN00884
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20253747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253747.